Abstract:We like to comment on the recently published article entitled “Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver Mutations” in the Journal of Thoracic Oncology. Deng et al.1Deng C. Zheng Q. Zhang Y. et al.Validation of the novel International Association for the Study of Lung Cancer grading system for invasive pulmonary adenocarcinoma and association with common driver mutations.J Thorac Oncol. 2021; 16: 1684-1693Google Scholar performed an interesting study regarding the prognostic significance of the novel grading system proposed by the International Association for the Study of Lung Cancer (IASLC) pathology committee and its correlations with common driver mutations and adjuvant chemotherapy. They found that the novel IASLC grading system was an efficient discriminator for patient prognosis. Nevertheless, we have some concerns. First, as illustrated in Supplementary Table 1, the authors presented the proportion of pathologic grades of lung adenocarcinoma according to the novel grading and previous predominant-based groups. There were 106 patients who were diagnosed with having well-differentiated adenocarcinoma according to predominant-based system, and 34 cases remained having grade 1 disease after reclassification, indicating 67.9% of the patients had high-grade patterns. Although patients with stages II to III were included in this study, this proportion was fairly higher compared with another two validation studies of the novel grading system. In the report of Kagimoto et al.,2Kagimoto A. Tsutani Y. Kambara T. et al.Utility of newly proposed grading system from International Association for the Study of Lung Cancer for invasive lung adenocarcinoma.JTO Clin Res Rep. 2020; 2: 100126Google Scholar there were 0.8% of patients upgrading from 1 to 3 after reclassification. Rokutan-Kurata et al.3Rokutan-Kurata M. Yoshizawa A. Ueno K. et al.Validation study of the International Association for the Study of Lung Cancer histologic grading system of invasive lung adenocarcinoma.J Thorac Oncol. 2021; 16: 1753-1758Google Scholar proposed that no patient with lepidic predominant patterns experienced upgrading after diagnosed with the novel grading system. Meanwhile, we consecutively reviewed 936 patients with invasive lung adenocarcinoma from January 2015 to December 2015 in three institutions, including Shanghai Pulmonary Hospital, the Second Affiliated Hospital of Soochow University, and Ningbo No. 2 Hospital. In our cohorts, 119 patients were previously diagnosed with having lepidic predominant adenocarcinoma and all of them were reclassified into grade 1 with the novel grading system, which was similar with the results of the aforementioned two studies. Thus, the high proportion of patients undergoing upgrading have probably affected the predictive performance of the IASLC grading system and previous predominant pattern-based system. Second, with regard to the prognostic impact of adjuvant chemotherapy in high-grade lung adenocarcinoma, the authors did not mention the predictive value of EGFR mutation status in multivariable survival analysis, neither with other mutations such as KRAS and ALK. It must be noted that the effectiveness of adjuvant chemotherapy would be affected by the status of driver mutations.4Shepherd F.A. Lacas B. Le Teuff G. et al.Pooled analysis of the prognostic and predictive effects of TP53 comutation status combined with KRAS or EGFR mutation in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapy.J Clin Oncol. 2017; 35: 2018-2027Google Scholar,5Woodard G.A. Kratz J.R. Haro G. et al.Molecular risk stratification is independent of EGFR mutation status in identifying early-stage non-squamous non-small cell lung cancer patients at risk for recurrence and likely to benefit from adjuvant chemotherapy.Clin Lung Cancer. 2021; 22: 587-595Google Scholar The evidence of the impact of adjuvant chemotherapy would be solid when the predictive value of common driver mutations was detailed. To sum up, the aforementioned points should be tackled before interpreting the results in clinical practice. Shenghui Li: Investigation, Methodology, Writing—original draft. Jiajun Deng: Validation, Writing—review and editing, Data curation. Yunlang She: Supervision, Visualization. Likun Hou: Resources, Supervision. Chang Chen: Conceptualization, Validation, Project administration. Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association With Common Driver MutationsJournal of Thoracic OncologyVol. 16Issue 10PreviewWe aimed to validate the use of the novel grading system proposed by the International Association for the Study of Lung Cancer pathology committee for prognosis stratification of invasive pulmonary adenocarcinomas (ADCs) in Chinese patients. Correlations between the grading system, common driver mutations, and adjuvant chemotherapy (ACT) were also investigated. Full-Text PDF Open ArchiveThe Grading System of Lung Adenocarcinoma: Ever-Evolving ConceptsJournal of Thoracic OncologyVol. 17Issue 3PreviewWe are thankful to Li et al. for their interest and commentary on our study validating the novel International Association for the Study of Lung Cancer grading system for invasive pulmonary adenocarcinoma (ADC).1 Their main concern centered on the relatively high proportion of patients upgrading to grade 3 on the basis of the novel grading system2 in our study. The architectural grading system only refers to the predominant histologic pattern, but most ADCs exhibit heterogeneous compositions. Moreover, the International Association for the Study of Lung Cancer grading system further classifies complex glandular patterns as high-grade patterns. Full-Text PDF Open Archive

Frozen Sections Accurately Predict the IASLC Proposed Grading System and Prognosis in Patients with Invasive Lung Adenocarcinomas

The IASLC Grading System for Invasive Pulmonary Adenocarcinoma: a Potential Prognosticator for Patients Receiving Neoadjuvant Therapy

The IASLC Proposed Grading System Accurately Predicts Prognosis and Mediastinal Nodal Metastasis in Patients With Clinical Stage I Lung Adenocarcinoma

Precise Diagnosis of Intraoperative Frozen Section is an Effective Method to Guide Resection Strategy for Peripheral Small-Sized Lung Adenocarcinoma.

Prediction of the Pathological Subtypes by Intraoperative Frozen Section for Patients with Ct1n0m0 Invasive Lung Adenocarcinoma (ECTOP-1015): a Prospective Multi-Center Study

Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section

Advances in the Accuracy of the Frozen Section (FS) Identification for Early-Stage Lung Adenocarcinoma

Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system

Prediction of Spread Through Air Spaces (STAS) By Intraoperative Frozen Section for Patients with cT1N0M0 Invasive Lung Adenocarcinoma: A Multi-Center Observational Study (ECTOP-1016)

Feasibility of intraoperative assessment of STAS in pathologic stage 1 lung adenocarcinomas in Chinese patients

Validation of the Novel International Association for the Study of Lung Cancer Grading System and Prognostic Value of Filigree Micropapillary and Discohesive Growth Pattern in Invasive Pulmonary Adenocarcinoma.

Computed tomography versus frozen sections for distinguishing lung adenocarcinoma: A cohort study of concordance rate

Integrating IASLC grading and radiomics for predicting postoperative outcomes in stage IA invasive lung adenocarcinoma

Predictors of Upstage and Treatment Strategies for Stage IA Lung Cancers after Sublobar Resection for Adenocarcinoma in Situ and Minimally Invasive Adenocarcinoma

Validation of the Novel International Association for the Study of Lung Cancer Grading System for Invasive Pulmonary Adenocarcinoma and Association with Common Driver Mutations.

[Prognostic Significance of a Newly Proposed Grading and Scoring System in Stage I Pulmonary Adenocarcinoma].

Clinical Thoughts on the Predictive Value of the Newly Proposed Grading System of Invasive Pulmonary Adenocarcinoma

A Novel Radiopathological Grading System to Tailor Recurrence Risk for Pathologic Stage IA Lung Adenocarcinoma.

Intraoperatively Measured Tumor Size and Frozen Section Results Should Be Considered Jointly to Predict the Final Pathology for Lung Adenocarcinoma.

Assessment of the feasibility of frozen sections for the detection of spread through air spaces (STAS) in pulmonary adenocarcinoma

Prognostic impact of the newly revised IASLC proposed grading system for invasive lung adenocarcinoma: a systematic review and meta-analysis